Teva legal chief Bergwerk reports 11,943 shares

The interim chief legal officer's restricted share unit schedules include vesting dates through March 4, 2030.

Rhea-AI Filing Summary

TEVA interim chief legal officer Dov Bergwerk reported direct holdings of 11,943 ordinary shares as of September 29, 2026. Reported holdings also include options covering 17,505 shares at $34.70, expiring March 3, 2027, and 8,755 shares at $28.98, expiring May 24, 2027. His restricted share unit balances are 16,742, 16,742, 10,719, 13,673 and 7,771 units; each represents a contingent right to one ordinary share or its cash value, at the compensation committee’s option.

Insider Trade Summary

8 transactions reported

Mixed 8 txns

Insider Bergwerk Dov

Role Interim Cheif Legal Officer

Type	Security	Shares	Price	Value
holding	Stock Options (right to buy) F1	--	--	--
holding	Stock Options (right to buy) F2	--	--	--
holding	Restricted Share Units F4, F3	--	--	--
holding	Restricted Share Units F4, F5	--	--	--
holding	Restricted Share Units F4, F6	--	--	--
holding	Restricted Share Units F4, F7	--	--	--
holding	Restricted Share Units F4, F8	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Stock Options (right to buy) — 26,260 contracts (Direct); Restricted Share Units — 65,647 contracts (Direct); Ordinary Shares — 11,943 shares (Direct)

Footnotes (8)

1. F1. Stock options were granted on March 3, 2017, with 4,376 having vested on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 4,377 having vested on March 3, 2021.
2. F2. Stock options were granted on May 24, 2017, with 2,188 having vested on each of May 24, 2018, May 24, 2019 and May 24, 2020 and 2,191 having vested on May 24, 2021.
3. F3. Restricted share units were granted on November 15, 2023, with 8,370 vested on each of November 15, 2024, November 15, 2025, 8,370 vesting on November 15, 2026, and 8,372 vesting on November 15, 2027.
4. F4. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
5. F5. Restricted share units were granted on March 4, 2024, with 8,370 vested on each of March 4, 2025 and March 4, 2026, 8,370 vesting on March 4, 2027, and 8,372 vesting on March 4, 2028.
6. F6. Restricted share units were granted on March 5, 2025, with 3,573 vested on March 5, 2026, and 3,573 vesting on each of March 5, 2027, March 5, 2028 and March 5, 2029.
7. F7. Restricted share units were granted on March 4, 2026, with 3,418 vesting on each of March 4, 2027, March 4, 2028 and March 4, 2029, and 3,419 vesting on March 4, 2030.
8. F8. Restricted share units were granted on March 3, 2023, with 7,768 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026 and 7,771 vesting on March 3, 2027.

Key Figures

Direct ordinary shares: 11,943 shares Stock options (underlying ordinary shares; exercise price): 17,505 shares at $34.70 per share Stock options (underlying ordinary shares; exercise price): 8,755 shares at $28.98 per share +5 more

8 metrics

Direct ordinary shares 11,943 shares Reported as of September 29, 2026

Stock options (underlying ordinary shares; exercise price) 17,505 shares at $34.70 per share Expires March 3, 2027

Stock options (underlying ordinary shares; exercise price) 8,755 shares at $28.98 per share Expires May 24, 2027

Restricted share units, November 15, 2023 grant 16,742 units Granted November 15, 2023; vesting dates include November 15, 2026 and November 15, 2027

Restricted share units, March 4, 2024 grant 16,742 units Granted March 4, 2024; vesting dates include March 4, 2027 and March 4, 2028

Restricted share units, March 5, 2025 grant 10,719 units Granted March 5, 2025; vesting dates include March 5, 2027, March 5, 2028 and March 5, 2029

Restricted share units, March 4, 2026 grant 13,673 units Granted March 4, 2026; vesting dates include March 4, 2027 through March 4, 2030

Restricted share units, March 3, 2023 grant 7,771 units Granted March 3, 2023; vesting date March 3, 2027

Key Terms

Stock Options (right to buy), Restricted share units, contingent right

3 terms

Stock Options (right to buy) financial

"Stock Options (right to buy)"

Restricted share units financial

"Restricted share units were granted on November 15, 2023"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

contingent right financial

"represents a contingent right to receive, at settlement"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TEVA ordinary shares did Dov Bergwerk report holding?

As of September 29, 2026, Dov Bergwerk reported direct ownership of 11,943 ordinary shares. He also reported options covering 17,505 and 8,755 ordinary shares and five restricted share unit balances of 16,742, 16,742, 10,719, 13,673 and 7,771 units.

When do Dov Bergwerk's TEVA restricted share units vest?

The 16,742 restricted share units granted November 15, 2023 include 8,370 units vesting on November 15, 2026 and 8,372 vesting on November 15, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/08/2026 - 04:01 PM Accepted by SEC EDGAR 10/08/2026 - 04:01 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Bergwerk Dov

(Last) (First) (Middle)

C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.

124 DVORA HA'NEVIA STREET

(Street)

TEL AVIV 6944020

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/29/2026

3. Issuer Name and Ticker or Trading Symbol
TEVA PHARMACEUTICAL INDUSTRIES LTD [ TEVA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim Cheif Legal Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	11,943	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	(1)	03/03/2027	Ordinary Shares	17,505	$34.7	D
Stock Options (right to buy)	(2)	05/24/2027	Ordinary Shares	8,755	$28.98	D
Restricted Share Units	(3)	(3)	Ordinary Shares	16,742	(4)	D
Restricted Share Units	(5)	(5)	Ordinary Shares	16,742	(4)	D
Restricted Share Units	(6)	(6)	Ordinary Shares	10,719	(4)	D
Restricted Share Units	(7)	(7)	Ordinary Shares	13,673	(4)	D
Restricted Share Units	(8)	(8)	Ordinary Shares	7,771	(4)	D

Explanation of Responses:

1. Stock options were granted on March 3, 2017, with 4,376 having vested on each of March 3, 2018, March 3, 2019 and March 3, 2020 and 4,377 having vested on March 3, 2021.

2. Stock options were granted on May 24, 2017, with 2,188 having vested on each of May 24, 2018, May 24, 2019 and May 24, 2020 and 2,191 having vested on May 24, 2021.

3. Restricted share units were granted on November 15, 2023, with 8,370 vested on each of November 15, 2024, November 15, 2025, 8,370 vesting on November 15, 2026, and 8,372 vesting on November 15, 2027.

4. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

5. Restricted share units were granted on March 4, 2024, with 8,370 vested on each of March 4, 2025 and March 4, 2026, 8,370 vesting on March 4, 2027, and 8,372 vesting on March 4, 2028.

6. Restricted share units were granted on March 5, 2025, with 3,573 vested on March 5, 2026, and 3,573 vesting on each of March 5, 2027, March 5, 2028 and March 5, 2029.

7. Restricted share units were granted on March 4, 2026, with 3,418 vesting on each of March 4, 2027, March 4, 2028 and March 4, 2029, and 3,419 vesting on March 4, 2030.

8. Restricted share units were granted on March 3, 2023, with 7,768 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026 and 7,771 vesting on March 3, 2027.

	/s/ Dov Bergwerk	10/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)